Total Funding
65
79
Total FundingPre-Seed raised
Growth Score 65 in past quarter
-2 pts
Heat Score 79 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
80515
Pharmaceutical development company located in Nashville, TN.
- Jim Monsor: CEO
About the Company
RLS Therapeutics is creating a novel small molecule therapeutic to treat a wide spectrum of disease states rooted in inflammation and cellular dysfunction processes in both animals and humans. Strong and compelling anecdotal data has led to the creation of several variants of the lead molecule. Our current lead drug candidate is focused on the
treatment of neurodegenerative disease.